当前位置: X-MOL 学术Cancer › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Compliance with sentinel lymph node biopsy guidelines for invasive melanomas treated with Mohs micrographic surgery
Cancer ( IF 6.2 ) Pub Date : 2021-07-22 , DOI: 10.1002/cncr.33651
Kelly M MacArthur 1 , Brian C Baumann 2 , Joseph F Sobanko 3 , Jeremy R Etzkorn 3 , Thuzar M Shin 3 , H William Higgins 3 , Cerrene N Giordano 3 , Stacy L McMurray 3 , Aimee Krausz 3 , Jason G Newman 4 , Karthik Rajasekaran 4 , Steven B Cannady 4 , Robert M Brody 4 , Giorgos C Karakousis 5 , John T Miura 5 , Justine V Cohen 6 , Ravi K Amaravadi 6 , Tara C Mitchell 6 , Lynn M Schuchter 6 , Christopher J Miller 3
Affiliation  

Sentinel lymph node biopsy (SLNB) has not been studied for invasive melanomas treated with Mohs micrographic surgery using frozen-section MART-1 immunohistochemical stains (MMS-IHC). The primary objective of this study was to assess the accuracy and compliance with National Comprehensive Cancer Network (NCCN) guidelines for SLNB in a cohort of patients who had invasive melanoma treated with MMS-IHC.

中文翻译:

符合 Mohs 显微手术治疗侵袭性黑色素瘤的前哨淋巴结活检指南

尚未对使用冰冻切片 MART-1 免疫组织化学染色 (MMS-IHC) 进行莫氏显微手术治疗的侵袭性黑色素瘤进行前哨淋巴结活检 (SLNB) 研究。本研究的主要目的是评估接受 MMS-IHC 治疗的侵袭性黑色素瘤患者队列中 SLNB 的准确性和遵守国家综合癌症网络 (NCCN) 指南的情况。
更新日期:2021-09-03
down
wechat
bug